To deal with rising costs, employers are leveraging high performance networks, variable copay plans and exclusive provider organization plans.

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

The letter is an extraordinary rebuke of the Trump administration’s actions against the NIH, which include: terminating hundreds of grants funding scientific and biomedical research; firing more than ...

Arkansas became the first state to pass a law banning pharmacy benefit managers from owning pharmacies, aiming to curb their market power and reduce drug costs. But major PBMs like CVS and Express ...

If enacted, the GOP’s spending bill could kick more than 10 million Americans off Medicaid. Experts are worried about the ...

Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, ...

Wisp, a women’s telehealth company, announced last week that it has launched a diagnostics arm, offering at-home test kits for several health conditions. New York City-based Wisp is a direct-to ...

On May 13, 2025, the U.S. House Committee on Ways and Means introduced a bill aimed at extending the 2017 tax cuts. The reconciliation bill, currently under consideration in Congress, includes ...

Earlier this year, the Department of Health and Human Services (HHS) issued a Notice of Proposed Rulemaking (NPRM) to amend the HIPAA Security Rule. The notice focused on modernizing security ...

It goes without saying that this past year has been anything but easy for UnitedHealth Group. As one of the biggest healthcare companies in the U.S., it has long been a reliable stock to invest in.

The Centers for Medicare and Medicaid Services (CMS) Final Rule impacting Star Ratings shows a clear shift in priorities to focus on health outcomes and equity, where success is defined less by ...